|
Yipin eyes global expansion in API and pharma pkg sectors
|
|
Our Bureau, Mumbai
June 26 , 2025
|
|
|
China-based Yipin Pharmaceutical Group is gearing up to expand its footprint globally, with a sharp focus on Active Pharmaceutical Ingredients (APIs) and pharmaceutical packaging materials. The group, which operates four manufacturing facilities—two for APIs and dosage forms and two for pharma packaging—has already made significant inroads into the Indian market, supplying to major companies like Sun Pharma and Orchid Pharma.
“We are a group company with a diversified portfolio. Along with manufacturing, we also operate a trading arm that exports APIs and dosage forms,” said a senior marketing representative of Yipin Pharmaceutical Group during the recent API China 2025 show.
The group’s API portfolio includes specialised compounds like isoflurane. India has emerged as a key export destination, reflecting strong demand from the country’s pharmaceutical giants.
While the company is actively involved in international trade, setting up a manufacturing base in India is not currently on the cards. “At the moment, there are no plans to establish manufacturing units in India. We already have four well-established factories in China,” the representative said, adding that such strategic decisions lie with the senior management.
In a notable shift, the company’s current marketing efforts are now centered around its pharmaceutical packaging division, specifically aluminium tubes used for ointments, creams, and gels. These tubes are manufactured to client specifications, without any in-house branding, functioning more as a custom contract manufacturer than an OEM.
“With aluminium being a locally sourced and cost-effective material in China, we are able to offer competitive pricing. This gives us a clear advantage in the global market,” the marketing manager noted.
Historically focused on the domestic Chinese market, Yipin Pharmaceutical is now using international trade shows as a launchpad for aggressive global expansion. “Our goal is market expansion. We believe our product quality and cost advantages position us well for international growth,” the company representative stated.
As the global pharmaceutical sector continues to evolve with increasing emphasis on quality packaging and reliable API supply chains, the group is positioning itself as a competitive player ready to meet international standards and demand.
|
|
|
|
|
|
|
|
TOPICS
|
Shanghai-based Hualian Pharmaceutical Machinery Company Limited, a family-run enterprise with roots going back to 1986, ...
|
|
|
|
|